The responsibility of research universities to promote access to essential medicines.
The responsibility of research universities to promote access to essential medicines.
复制标题
研究型大学有责任促进基本药物的获取。
DOI：
--
复制
发表时间：
2003
期刊：
影响因子：
--
通讯作者：
E. Hoen
中科院分区：
文献类型：
--
作者：
E. Hoen
世界上三分之一的人口无法获得基本药物。在非洲和亚洲最贫穷的地区，这一数字上升到一半。这场全球健康和药品危机是微生物对老药的抗药性增加、现有无利可图的药品停产以及许多药品价格过高的结果。此外，目前正在开发的用于治疗影响贫穷国家人民的重大疾病的新药很少。许多其他因素也造成获得基本药品的机会有限的问题，包括后勤供应和储存问题、药品质量不合格以及药品的选择和使用不当。这篇文章重点关注大学在帮助改善发展中国家药品可及性方面可以发挥的作用。在美国，大多数基础医学研究都在大学进行。大学可以采取措施，增加与发展中国家卫生有关的研究数量。大学还拥有许多重要药物的专利。通过负责任地管理这一知识产权，大学可以做很多事情来确保发展中国家获得医疗创新。
One-third of the world’s population lacks access to essential medicines. In the poorest parts of Africa and Asia, this figure climbs to one-half. This global health and medicines crisis is the result of increased microbial resistance to older medicines, discontinued production of unprofitable existing medicines, and the prohibitive price of many drugs. In addition, very few new drugs are being developed to tackle major diseases affecting people in poor countries. Many other factors also contribute to the problem of limited access to essential medicines, including logistical supply and storage problems, substandard drug quality, and the inappropriate selection and use of drugs. This piece focuses on the role universities can play in helping to improve access to medicines in developing countries. Most basic medical research in the United States takes place at universities. Universities can take steps to increase the amount of research relevant to health in the developing world. Universities also hold patents on many important medicines. By managing this intellectual property (IP) responsibly, universities can do much to ensure access to medical innovations in developing countries.